Capsid Characterization Services for Vaccines and Viral Vectors
For recombinant protein vaccines and viral vector development, including adeno-associated virus (AAV) development, viral capsid characterization with peptide mapping is an important step for ensuring drug product safety and consistency.
Whether you’re developing a viral vector for a novel gene therapy or a preclinical vaccine, Prolytix has the scientific expertise to help move your product forward with agility and speed.
High-Resolution Mass Spectrometry and Capsid Characterization
We use LC-MS/MS — liquid chromatography (LC) with tandem high-resolution mass spectrometry (HRMS) — as well as several other applicable methods to develop peptide maps for capsid proteins. Our precise characterizations give you the identification and sequence coverage information needed for vaccine and viral vector projects.